UK markets open in 3 hours 53 minutes

Theravance Biopharma, Inc. (TBPH)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
9.52-0.17 (-1.75%)
At close: 04:00PM EDT
9.35 -0.17 (-1.79%)
After hours: 04:06PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4444
Avg. Estimate-0.25-0.21-0.68-0.4
Low estimate-0.4-0.28-0.96-0.75
High estimate-0.16-0.18-0.30.32
Year ago EPS-0.35-0.28-1-0.68
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4444
Avg. Estimate13.96M15.6M71.1M83.2M
Low estimate11.1M14.7M61.4M73.7M
High estimate15.75M17.18M87.5M96.55M
Year ago sales13.84M13.75M57.42M71.1M
Sales growth (year/est)0.90%13.50%23.80%17.00%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.26-0.21-0.21-0.15
Actual EPS-0.35-0.28-0.17-0.17
Difference-0.09-0.070.04-0.02
Surprise %-34.60%-33.30%19.00%-13.30%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.25-0.21-0.68-0.4
7 days ago-0.25-0.22-0.64-0.32
30 days ago-0.25-0.22-0.64-0.32
60 days ago-0.25-0.23-0.61-0.2
90 days ago-0.25-0.23-0.61-0.2
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesTBPHIndustrySector(s)S&P 500
Current qtr.28.60%N/AN/AN/A
Next qtr.25.00%N/AN/AN/A
Current year32.00%N/AN/AN/A
Next year41.20%N/AN/AN/A
Next 5 years (per annum)54.10%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A